Latest Monoclonal Antibody Treatment Approved for High-Risk Patients

admin May 26, 2021
The drug, from GlaxoSmithKline and Vir, aims to keep Covid patients out of the hospital.

source https://www.nytimes.com/2021/05/26/business/covid-monoclonal-antibody-treatment-approved.html

Post a Comment

0 Comments